rhodium has been researched along with Liver Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, M; Fan, R; Hu, L; Liu, W | 1 |
| Ahlman, H; Bernhardt, P; Forssell-Aronsson, E | 1 |
| Lee, G; Piquette-Miller, M | 1 |
| Dehand, J; Jordanov, J | 1 |
| Brindley, DN; Cascales, C; Cascales, M; Hopewell, R; Martin-Sanz, P; Pittner, RA | 1 |
5 other study(ies) available for rhodium and Liver Neoplasms
| Article | Year |
|---|---|
A new rhodium(I) NHC complex inhibits TrxR: In vitro cytotoxicity and in vivo hepatocellular carcinoma suppression.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Membrane Permeability; Cell Survival; Coordination Complexes; Cyclooctanes; Drug Design; Hep G2 Cells; Humans; Imidazoles; Liver Neoplasms; Male; Membrane Potential, Mitochondrial; Mice, Nude; Molecular Structure; Reactive Oxygen Species; Rhodium; Structure-Activity Relationship; Thioredoxin-Disulfide Reductase | 2019 |
Model of metastatic growth valuable for radionuclide therapy.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Division; Computer Simulation; Dose-Response Relationship, Radiation; Humans; Liver Neoplasms; Lutetium; Models, Biological; Neoplasm Staging; Prognosis; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Computer-Assisted; Relative Biological Effectiveness; Rhodium; Treatment Outcome; Yttrium Radioisotopes | 2003 |
Influence of IL-6 on MDR and MRP-mediated multidrug resistance in human hepatoma cells.
Topics: Blood Proteins; Blotting, Western; Carcinoma, Hepatocellular; Cytokines; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluoresceins; Gene Expression Regulation, Neoplastic; Genes, MDR; Humans; Interleukin-6; Liver Neoplasms; Radioisotopes; Reverse Transcriptase Polymerase Chain Reaction; Rhodium; RNA, Messenger; Tumor Cells, Cultured | 2001 |
Anti-tumour activity of heavy transition metal complexes against hepatoma cells.
Topics: Animals; Carcinoma, Hepatocellular; Liver Neoplasms; Neoplasms, Experimental; Organometallic Compounds; Palladium; Platinum; Rats; Rhodium; Structure-Activity Relationship; Sulfhydryl Compounds | 1975 |
Effects of an antitumoural rhodium complex on thioacetamide-induced liver tumor in rats. Changes in the activities of ornithine decarboxylase, tyrosine aminotransferase and of enzymes involved in fatty acid and glycerolipid synthesis.
Topics: Acetamides; Acetyl-CoA Carboxylase; Animals; Antineoplastic Agents; ATP Citrate (pro-S)-Lyase; Body Weight; Diglycerides; Fatty Acid Synthases; Fatty Acids; Glycerides; Glycerol Kinase; Glycerol-3-Phosphate O-Acyltransferase; Isoenzymes; L-Lactate Dehydrogenase; Liver; Liver Neoplasms; Malate Dehydrogenase; Male; Organ Size; Ornithine Decarboxylase; Phosphatidate Phosphatase; Rats; Rats, Inbred Strains; Rhodium; Thioacetamide; Triglycerides; Tyrosine Transaminase | 1986 |